MQSA Panel Urges “Relevant” Equipment Testing To Limit Facility Downtime
This article was originally published in The Gray Sheet
Executive Summary
FDA needs to identify a way to evaluate mammography equipment components that does not incapacitate testing facilities, according to the agency's National Mammography Quality Assurance Advisory Committee